Form 8-K - Current report:
SEC Accession No. 0001213900-20-011769
Filing Date
2020-05-12
Accepted
2020-05-12 10:51:55
Documents
7
Period of Report
2020-05-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea121673-8k_citiuspharma.htm 8-K 17881
2 LETTER TO SHAREHOLDERS MAY 2020. ea121673ex99-1_citiuspharma.htm EX-99.1 30940
3 GRAPHIC image_002.jpg GRAPHIC 3093
4 GRAPHIC image_003.jpg GRAPHIC 106783
5 GRAPHIC image_005.jpg GRAPHIC 6942
6 GRAPHIC image_006.jpg GRAPHIC 2411
7 GRAPHIC image_007.jpg GRAPHIC 2837
  Complete submission text file 0001213900-20-011769.txt   218897
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 20867153
SIC: 2834 Pharmaceutical Preparations